发明名称 |
Alkylaminoalkylamino and -ether compounds as well as processes and intermediates for their preparation, and medicaments containing these compounds |
摘要 |
<p>Pharmacologically active compounds corresponding to the formula I <IMAGE> in which n represents 2-5, m represents 2-6, R1 denotes hydrogen or lower alkyl, R2 represents an OR4 group in which R4 denotes lower alkyl or a phenyl or phenyl-lower alkyl group which is optionally substituted in the phenyl ring, or R2 represents a <IMAGE> group in which R5 and R6 independently of one another each denote hydrogen, lower alkyl or a phenyl or phenyl-lower alkyl group which is optionally substituted in the phenyl ring, or R5 and R6, together with the nitrogen atom to which they are bonded, represent a saturated 5- or 6-membered heterocycle, R3 represents a saturated monocyclic or bicyclic hydrocarbon group which is derived from terpenes and has 10 or 11 carbon atoms, and Z represents oxygen or, if R3 is a dihydronopyl group, Z may also represent sulfur, and salts thereof.</p> |
申请公布号 |
GR3019921(T3) |
申请公布日期 |
1996.08.31 |
申请号 |
GR19960401136T |
申请日期 |
1996.05.16 |
申请人 |
KALI-CHEMIE PHARMA GMBH |
发明人 |
KRAEHLING, HERMANN;DAVID, SAMUEL;HELL, INSA, DR.;PREUSCHOFF, ULF;BAN, IVAN;CHRISTEN, MARIE-ODILE |
分类号 |
A61K31/13;A61K31/335;A61K31/357;A61K31/535;A61K31/54;A61P1/00;A61P1/08;A61P25/04;C07C217/08;C07C217/12;C07C217/14;C07C217/28;C07C217/42;C07C323/26;C07C323/32;C07D295/12;C07D295/13;C07D317/58;(IPC1-7):C07D295/12 |
主分类号 |
A61K31/13 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|